Influence of antiTNF-alpha antibody treatment on fracture healing under chronic inflammation. - Wikidata - wikimedia - TriplyDB

Influence of antiTNF-alpha antibody treatment on fracture healing under chronic inflammation.

Influence of antiTNF-alpha antibody treatment on fracture healing under chronic inflammation.

http://www.wikidata.org/entity/Q33761069

about

Anti-inflammatory effects of infliximab in mice are independent of tumour necrosis factor α neutralization.Diminished bone regeneration after debridement of posttraumatic osteomyelitis is accompanied by altered cytokine levels, elevated B cell activity, and increased osteoclast activity.

P2860

Q39350996-85225809-C50E-4D7A-8250-71AA0E38C512 Q40306963-F73C1B40-83E2-41BF-9D5D-6CB7BBAB0F6B

P2860

Influence of antiTNF-alpha antibody treatment on fracture healing under chronic inflammation.

http://www.wikidata.org/entity/Q33761069

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Influence of antiTNF-alpha ant ...... ng under chronic inflammation.

@ast

Influence of antiTNF-alpha ant ...... ng under chronic inflammation.

@en

type

label

Influence of antiTNF-alpha ant ...... ng under chronic inflammation.

@ast

Influence of antiTNF-alpha ant ...... ng under chronic inflammation.

@en

prefLabel

Influence of antiTNF-alpha ant ...... ng under chronic inflammation.

@ast

Influence of antiTNF-alpha ant ...... ng under chronic inflammation.

@en

P1433

Q33761069-55CAD660-7A74-4AD0-B573-69E1A116FD4C

P1476

Q33761069-58F994B5-12A5-4491-BF79-3D9E8E461CB4

P2093

Q33761069-07F5E117-C034-4AE6-AA4F-B62D4383435B

Q33761069-0C7CBF93-DCAA-493E-9920-E2F84B9ECEDC

Q33761069-1B9B5B31-CD60-4BB7-A678-A29D1DCE3852

Q33761069-26424ACB-E66A-4E56-B446-0FEC65EE67CC

Q33761069-3643B5BA-7F12-4B17-B859-EF21ADCC3131

Q33761069-7DEF9951-D8B6-4C0D-AE00-60FA4BCD5553

Q33761069-A4167F41-21CE-4D41-BFD0-A597A8640510

Q33761069-F5302E33-0179-4A21-A7FC-36289781F371

P2860

Q33761069-1B623F2C-A0A9-44B5-A5AE-02038AA70618

Q33761069-22C46C56-347D-4436-81A5-EC644D308C1A

Q33761069-27F02BCB-143F-46BE-97F2-7BC585FEF3F4

Q33761069-2D054B53-B219-47F6-AA90-00BEA8A1606D

Q33761069-2D6CAE5F-C6E8-4785-A11A-7AF14216376A

Q33761069-3A411702-FD75-48D9-9031-CF327FCFCACE

Q33761069-49645252-8B18-4470-8B31-E600187259D1

Q33761069-4AE4B80A-7B48-4C74-9F9C-3F31ECF60086

Q33761069-4B4BE42D-00AE-4698-A815-7B0CE95D7A3E

Q33761069-4B8329AD-B0A7-4836-8B2D-0BAF0D59D068

P2888

Q33761069-D560E638-D496-43AF-B7C0-B64D98C711B4

P304

Q33761069-F246869E-9F26-4013-8BB4-265462CC4684

P31

Q33761069-D429C2F8-38D5-4C45-A6F2-EA937C3D1675

P356

Q33761069-C15AAF3D-5468-4C9C-A09F-E54FD00C69F7

P478

Q33761069-D967EA5F-CADF-4F0A-837E-E89C4103E5D5

P50

Q33761069-1E43EA32-66F9-41F1-818B-AC3D10A35C35

P577

Q33761069-0C342A23-09BB-4FA5-89F5-3BFE1845AC6B

P5875

Q33761069-38286F43-98DC-44CF-827A-F61DE1E64F3E

P6179

Q33761069-9EF8232A-7D63-4972-B2BE-9D5B7AAF168B

P698

Q33761069-CCFA338D-36A6-4049-9E84-7E363F3F31E1

P921

Q33761069-0867243B-9825-4F88-B195-3B8A869F7F68

P932

Q33761069-5AC869BD-6B5F-4548-9183-771324785C02

P356

1471-2474-15-184

P1433

BMC Musculoskeletal Disorders

P1476

Influence of antiTNF-alpha ant ...... ng under chronic inflammation.

@en

P2093

Britta Wieskötter

http://www.w3.org/2001/XMLSchema#string

Heriburg Hidding

http://www.w3.org/2001/XMLSchema#string

Jochen Zwerina

http://www.w3.org/2001/XMLSchema#string

Melanie Timmen

http://www.w3.org/2001/XMLSchema#string

Michael J Raschke

http://www.w3.org/2001/XMLSchema#string

Richard Stange

http://www.w3.org/2001/XMLSchema#string

Thomas Pap

http://www.w3.org/2001/XMLSchema#string

Wolfgang Baum

http://www.w3.org/2001/XMLSchema#string

P2860

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

Cytokines in acute and chronic inflammation

The pathogenesis of rheumatoid arthritis

Tumor necrosis factor alpha (TNF-alpha) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing.

The biology of fracture healing.

The TNF-alpha transgenic mouse model of inflammatory arthritis.

Etanercept does not impair healing in rat models of tendon or metaphyseal bone injury

Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases

Tumor necrosis factor antagonist mechanisms of action: a comprehensive review.

P2888

1471-2474-15-184

P304

184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2474-15-184

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262789306

http://www.w3.org/2001/XMLSchema#string

P6179

1031721150

http://www.w3.org/2001/XMLSchema#string

P698

24885217

http://www.w3.org/2001/XMLSchema#string

P921

P932

4059090

http://www.w3.org/2001/XMLSchema#string